Corporate Luncheon Workshops
The Corporate Luncheon Workshops are independent from the ISLH educational content. Please review the available workshops below and pre-register for any workshops that you wish to attend. There is no cost to attend these workshops. Corporate luncheon workshops are limited to meeting attendees. Details are subject to change.
How to Register
If you have already registered for the conference
You may access the workshop registration system by logging into your account
and clicking on the "Register Now" link in the Luncheon Workshop column of your conference registration record.
If you have not yet registered for the conference
to first submit your conference registration. You will then be able to register for a luncheon workshop.
Thursday, May 12
(12:00 PM - 1:30 PM)
Analytical Evaluation of the CP3000 coagulationanalyzer
Dr. Larry Smith. Medical and Scientific Affairs Liaison Manager in the Hematology Business Unit in Abbott Diagnostics Division in Santa Clara
Dr. Smith will present the results of the first analytical performance study of the CP3000 coagulation analyzer and the reagents released until present.
Emerging topics in blood coagulation
He will also give an overview of vWD including current classification, structure and function of the vWF molecule, current laboratory assays used for screening and confirmation of vWD, limitations and preanalytical variable affecting interpretation of assays.
Advancing healthcare in every hematology lab, for every patient via workflow and scientific advancements.
Anna Maria Cenci, SIPMeL – Società Italiana di Patologia Clinica e Medicina di Laboratorio, Italy
1. Dr. Fabrizio Papa, Hospital “San Giovanni Calibita” Fatebenefratelli, Rome, Italy.
Clinical and performance evaluation of Beckman Coulter DxH500 hematology analyzer.
2. Dr. Germán Pérez Vázquez, University Hospital Marqués de Valdecilla, Santander, Spain.
Improving productivity with Beckman Coulter DxH800 connectivity and automation solutions: A university hospital hematology lab experience
3. Dr. Olivier Pradier, Erasme Hospital, Université Libre, Brussels, Belgium.
Effective screening for sepsis in critically ill adult patients using DxH 800 AIM technology
Beckman Coulter’s workshop will be focused on two key aspects: instrumentation available today for hematology laboratories both small and large and how modern technology can improve healthcare.
You will learn about the new DxH 500, a small 5 part diff hematology analyzer, its analytical performance and how it can be benefical for laboratories; then you will hear the experiences from a high volume lab with automation and DxH800 Connectivity. Finally you will discover how Beckman Coulter’s technology may advance healthcare with the example of sepsis screening in intensive care units utilizing the power of the DxH 800’s Automated Intelligent Morphology (AIM) technology.
Know more. Decide with Confidence. Act Faster.
Dr. Mauro Butarello
Dr. Henk Russcher
Dr. Pieter Steenhuis
Wouter Anton van der Heijden
Friday, May 13
(12:00 PM - 1:30 PM)
Cobas m 511 Integrated Hematology Analyzer: Overview of the Technology and First Experiences in a Clinical Laboratory
Dr. Henk Russcher
SEBIA electrophoresis for Hemoglobin and VWF multimers: better, faster, stronger.
Pr. Marc VASSE, Foch Hospital, Suresnes, France
SEBIA keeps innovating in the hematology field to bring solutions to laboratories for the screening and management of hematological disorders. By attending this workshop, the audience will discover why Capillary Electrophoresis is the best-in-class technique for first intention hemoglobinopathies testing and how the diagnosis of von Willebrand disease can be simplified thanks to a new electrophoresis application.
1/ Advantages of Capillary Electrophoresis for hemoglobinopathies’ diagnosis: valuable feedback from years of routine use.
Dr. Mariela MARINOVA, University of Padova, Padova, Italy
Dr. Mariela MARINOVA will explain why the laboratory has chosen Capillary Electrophoresis as first-line technique for the screening and the diagnosis of hemoglobinopathies and thalassemias. Based on several years of experience and routine use, she will demonstrate how this breakthrough technology, thanks to better analytical performances and ergonomics, has improved the diagnosis of these diseases and has brought high medical added values for patients.
2/ Revolutionizing multimer analysis test: Within-day results with Sebia Hydragel von Willebrand factor (VWF) multimer analysis test.
Dr. Annette BOWYER, Sheffield Haemophilia and Thrombosis centre, UK
Dr. Annette BOWYER will describe preliminary results of a comparative evaluation of the Sebia Hydragel von Willebrand factor (VWF) assay compared to an in-house agarose gel electrophoresis method for VWF multimer analysis. The Sebia’s assay clearly reduces time for obtaining results (within-day results) compared to current home-brew techniques (4 days in average). In addition, this study will determine whether the Hydragel densitometric analysis will improve the interpretation of multimers result and the correlation between the two techniques for VWD typing.
Saturday, May 14
(11:45 AM - 1:15 PM)
Managing the Process of Performing Cell Differentials in Large Healthcare Networks – An Exploration of Organizational Challenges and Tools for Change.
Mrs Kristy Carnevale, Lab Manager at Cincinnati Children’s Hospital in the USA, will share experiences from implementing Digital Cell Morphology in their multi-site network, focusing on how improved network connectivity and remote accessibility has helped standardize differential testing while improving resource utilization, facilitating collaboration and enhancing communication within and between laboratory sites.
Mrs Camilla Streimer, Lab Process Manager at Region Skåne Healthcare Network in Sweden, will present how they have leveraged Digital Cell Morphology to standardize morphological cell analysis, placing particular emphasis on experiences gained from implementing and working with supporting CellaVision software designed to simplify proficiency testing and competency promotion.
Dr. Elizabeth Broome, Clinical Professor of Pathology at Moores UCSD Cancer Center in the USA, will share some interesting preliminary results from a study designed to evaluate if a CellaVision DM system paired with a relatively inexpensive hematology analyzer could match the clinical information delivered by a more sophisticated hematology analyzer alone.
The Chromogenic Assay: Considerations for the Monitoring of Extended Half-life Molecules in Haemophilia
Armando Tripodi, Milan, Italy
A computer-based model to assess costs associated with the use of one-stage and chromogenic factor activity assays
Steve Kitchen, Sheffield, UK
Recovery of select novel recombinant FVIII and FIX replacement products in commonly used one-stage factor activity assays
Stefan Tiefenbacher, Englewood, CO, USA
Mechanistic studies to explain inconsistencies in the performance of silica-based aPTT reagents
Steffen Rosén, Molndal, Sweden